AI-generated analysis. Always verify with the original filing.
Bioxytran, Inc. completed a private placement on March 18, 2026, issuing 21,071,667 shares of common stock at $0.055 per share for $1.2 million gross proceeds and warrants for 19,750,001 shares at $0.12 exercise price. The net proceeds will fund working capital and general corporate purposes, strengthening the balance sheet for development initiatives.
Event Type
Disclosure
Mandatory
Variant
8-K
Unregistered Sales of Equity Securities. On March 18, 2026, the Company completed the closing of a private placement of unregistered shares of common stock unde
. Other Events On March 20, 2026, the Company issued a press release, a copy of which is attached hereto as Exhibit 99.1, under the title: Bioxytran, Inc. Compl
Financial Statements and Exhibits. Exhibit Number Description 99.1* Press Release dated March 20, 2026, entitled “Bioxytran, Inc. Completes $1.2 Million Private